NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...
Equities research analysts at Wedbush boosted their Q3 2025 earnings per share estimates for shares of Genuine Parts in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback